HSDT heliusmedical.com: Year-over-year earnings per share growth for the last twelve months
Helius Medical (HSDT) faces liquidity risks due to its reliance on a single device and insurance challenges; however, this quarterly earnings per share (EPS) growth chart on GURU.Markets highlights the impact of PoNS system expansion into US clinics and the use of outsourced electronics manufacturing, with the current figure standing at 99.30.
Analytical breakdowns for Helius Medical
- share price and consensus valuation forecast:
- company stock capitalization data:
- book capitalization data:
- debt level and financial liquidity data:
Total Debt to Capital Helius Medical|HSDT - Long-Term Liabilities to Capital|Short-Term Debt to Capital heliusmedical.com|HSDT - Company Aggregate Debt|Debts to Book Capitalization Helius Medical Technologies Inc.|HSDT - Long-Term Debt Volume|Company Short-Term Debts Helius Medical Technologies|Quick Ratio heliusmedical.com
- earnings and valuation multiples information:
HSDT - Net Profit|Expected Profit Helius Medical|HSDT - Price to Earnings Ratio|Forward P/E Multiple heliusmedical.com|HSDT - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Helius Medical Technologies Inc.|HSDT - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Helius Medical Technologies|HSDT - Earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months heliusmedical.com|HSDT - Net earnings per one share growth for the current year|Net earnings per share growth forecast for next year Helius Medical
Summary company analysis:Helius Medical Technologies, Inc. - HSDT
Quarterly earnings per share growth serves as an objective filter for market reactions to 10-Q reports, eliminating investor cognitive biases when assessing real returns. Analyzing the history of quarterly EPS growth allows for tracking the scaling pace of net income, which is critically important for Helius Medical (HSDT) during the expansion of high-margin PoNS systems within the neurotechnology segment for patient rehabilitation.
Competitors of Helius Medical (HSDT)
BIIB (Biogen) - Year-over-year net earnings per share growth for the last 12 months|Neurocrine (NBIX) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Regencell|Axsome Corp (AXSM) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months ACAD (ACADIA Pharmaceuticals)|XENE (xenon-pharma.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Viking Therapeutics, Inc. VKTX|SUPN - Year-over-year net earnings per share growth for the last 12 months|Catalyst Pharmaceuticals Inc - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Denali Corp|HRMY: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months BHVN|AMLX (Amylyx Pharmaceuticals, Inc.) - Quarterly EPS earnings growth|Trevi Therapeutics Inc (TRVI) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth PRAX|Year-over-year net earnings per share growth for the last 12 months Anavex Life Sciences Corp AVXL|Quarterly EPS earnings growth CBLL (CeriBell, Inc.)|Quarterly EPS earnings growth prothena.com PRTA|ALEC - Year-over-year earnings per share growth for the last twelve months|ANNX: Year-over-year earnings per share growth for the last twelve months|OMER: Quarterly EPS earnings growth|Neurogene Therapeutics - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months AC Immune|voyagertherapeutics.com (VYGR) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth NMRA|Scilex Holding - Year-over-year earnings per share growth for the last 12 months|Tevogen Bio Holdings, Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months ACOG (Alpha Cognition Inc)|CGTX - Year-over-year earnings per share growth for the last twelve months|IKT (inhibikase.com) - Year-over-year earnings per share growth for the last 12 months|SAVA: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Assertio (ASRT)|Year-over-year net earnings per share growth for the last 12 months COYA|Quarterly EPS earnings growth VistaGen Therapeutics Inc|Year-over-year earnings per share growth for the last twelve months Ovid Therapeutics Inc. (OVID)|ABOS (acumenpharm.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months CervoMed CRVO|Alterity Therapeutics Ltd. (ATHE) - Earnings per share growth in annualized terms for the last twelve months|Clene Nanomedicine - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months PEPG (PepGen Inc.)|JUNS: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months relmada.com (RLMD)|Year-over-year earnings per share growth for the last twelve months Annovis Bio|Year-over-year earnings per share growth for the last twelve months GRCE|Quarterly EPS earnings growth AIFF|Year-over-year net earnings per share change for the last twelve months anewmeds.com|NeuroSense Therapeutics Ltd. - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth revivapharma.com RVPH|MTVA - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months NeurAxis Inc. NRXS|PASG (passagebio.com) - Year-over-year net earnings per share growth for the last 12 months|Neuphoria Therapeutics - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Minerva Neurosciences|Year-over-year net earnings per share growth for the last 12 months athira.com (ATHA)|Quarterly EPS earnings growth ADXN|ALZN - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth CYCN (Cyclerion Therapeutics, Inc.)|PTIX: Year-over-year earnings per share growth for the last 12 months|Pasithea - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Cortigent, Inc. CRGT|ATXI: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Brainstorm Cell Therapeutics Inc.|CARA (Cara Therapeutics, Inc) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Chromocell|Year-over-year earnings per share growth for the last twelve months Eliem Therapeutics (ELYM)|Year-over-year earnings per share growth for the last twelve months ITCI (intracellulartherapies.com)|Quarterly EPS earnings growth LBPH (Longboard Pharmaceuticals, Inc.)|Year-over-year earnings per one share growth for the last 12 months MRNS|NKGN - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months NeuroBo Pharma NRBO|SAGE: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months SNPX|Year-over-year net earnings per share growth for the last 12 months TRVN|VIGL (Vigil Neuro) - Year-over-year earnings per share growth rate for the last twelve months|Year-over-year earnings per share growth for the last twelve months Anew Medical, Inc. (WENA)|Cerevel Corp - Year-over-year earnings per share growth for the last 12 months
